Back to Search
ANNE-MARIE DULIEGE, M.D., M.S.
M.D., M.S.
Pediatric Adolescent Medicine Physician
NPI: 1053445452Individual
Specialties, Licenses & Credentials
Pediatric Adolescent Medicine PhysicianPrimary
Pediatrics — Adolescent Medicine
Code: 2080A0000X
A49992(CA)
Research & Publications (17)
Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist (ERA) in healthy volunteers.
PMID 18025524·J Clin Pharmacol·2008
8-other
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
PMID 17389292·Arch Intern Med·2007
2-rct
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.
PMID 16720830·Blood·2006
3-trial
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.
PMID 14585211·AIDS Res Hum Retroviruses·2003
3-trial
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.
PMID 12854076·J Infect Dis·2003
3-trial
A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cells.
PMID 12706405·Clin Immunol·2003
3-trial
Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
PMID 11865427·J Infect Dis·2002
3-trial
Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers.
PMID 11840080·Pediatr Infect Dis J·2002
3-trial
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
PMID 11679925·J Infect Dis·2001
3-trial
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
PMID 11294665·J Infect Dis·2001
3-trial
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.
PMID 11229849·Clin Infect Dis·2001
3-trial
A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.
PMID 11024131·J Virol·2000
3-trial
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.
PMID 10889591·JAMA·2000
3-trial
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.
PMID 10875616·AIDS Res Hum Retroviruses·2000
3-trial
Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin.
PMID 10733168·Viral Immunol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 725 WELCH RD
PALO ALTO, CA 94304 - Phone
- (650) 812-8727
Quick Facts
- NPI
- 1053445452
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile